These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 34291376)

  • 1. Delayed Hypersensitivity Reactions Following First Dose of the SARS-CoV2 mRNA Vaccines.
    Xu J; Vanijcharoenkarn K; Sexton ME; Martin L; Lee FE; Kuruvilla ME
    J Gen Intern Med; 2021 Oct; 36(10):3298-3300. PubMed ID: 34291376
    [No Abstract]   [Full Text] [Related]  

  • 2. 'COVID arm' - histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine.
    Kempf W; Kettelhack N; Kind F; Courvoisier S; Galambos J; Pfaltz K
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e730-e732. PubMed ID: 34242422
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis.
    Lindgren AL; Austin AH; Welsh KM
    J Prim Care Community Health; 2021; 12():21501327211024431. PubMed ID: 34120504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Klimek L; Chaker AM; Cuevas M
    Laryngorhinootologie; 2021 Mar; 100(3):168-173. PubMed ID: 33482671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed localized hypersensitivity reactions to COVID-19 mRNA vaccines: a 6-month retrospective study.
    Papadimitriou I; Bakirtzi K; Sotiriou E; Vakirlis E; Hatzibougias D; Ioannides D
    Clin Exp Dermatol; 2022 Jan; 47(1):157-158. PubMed ID: 34288056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Dyskinesia After Administration of SARS-CoV2 mRNA Vaccine in Parkinson's Disease.
    Erro R; Buonomo AR; Barone P; Pellecchia MT
    Mov Disord; 2021 Oct; 36(10):2219. PubMed ID: 34368991
    [No Abstract]   [Full Text] [Related]  

  • 8. [Not Available].
    Klimek L; Chaker AM; Cuevas M
    Laryngorhinootologie; 2021 Apr; 100(4):252-258. PubMed ID: 33524996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypersensitivity reactions to vaccines in children: from measles to SARS-CoV-2.
    Caffarelli C; Liotti L; Bianchi A; Bottau P; Caimmi S; Crisafulli G; Franceschini F; Paglialunga C; Saretta F; Mori F
    Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):58-60. PubMed ID: 35080320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
    Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
    Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported allergy to medications containing the same excipients as SARS-CoV2 vaccines: importance of skin testing with excipients.
    Biondi F; Bianchi L; Tramontana M; Marietti R; D'Arpino A; Hansel K; Stingeni L
    Ital J Dermatol Venerol; 2023 Feb; 158(1):72-73. PubMed ID: 36421077
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypersensitivity Reactions to Vaccines: Current Evidence and Standards for SARS-CoV-2 Vaccines.
    Carvalho JC; Cunha F; Coutinho IA; Loureiro C; Faria E; Bom AT
    Acta Med Port; 2021 Jun; 34(7-8):541-547. PubMed ID: 34851819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.
    Blumenthal KG; Freeman EE; Saff RR; Robinson LB; Wolfson AR; Foreman RK; Hashimoto D; Banerji A; Li L; Anvari S; Shenoy ES
    N Engl J Med; 2021 Apr; 384(13):1273-1277. PubMed ID: 33657292
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19.
    Juárez Guerrero A; Domínguez Estirado A; Crespo Quirós J; Rojas-Pérez-Ezquerra P
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3811-3813. PubMed ID: 34293500
    [No Abstract]   [Full Text] [Related]  

  • 16. RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge.
    Wong TY; Russ BP; Lee KS; Miller OA; Kang J; Cooper M; Winters MT; Rodriguez-Aponte SA; Dalvie NC; Johnston RS; Rader NA; Wong ZY; Cyphert HA; Martinez I; Shaligram U; Batwal S; Lothe R; Chandrasekaran R; Nagar G; Rajurkar M; Rao H; Bevere JR; Barbier M; Love JC; Damron FH
    mSphere; 2022 Aug; 7(4):e0024322. PubMed ID: 35968964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2.
    Sprute R; Schumacher S; Pauls M; Pauls W; Cornely OA
    Drugs R D; 2021 Dec; 21(4):371-374. PubMed ID: 34351606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient Lymphocytic Colitis After SARS-CoV2 mRNA Vaccine.
    Chey SW; Westerhoff M; Chey WD
    Am J Gastroenterol; 2022 Apr; 117(4):685-687. PubMed ID: 35130188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response after two doses of homologous or heterologous SARS-CoV-2 vaccines in healthcare workers at health promotion centers: A prospective observational study.
    Nah EH; Cho S; Park H; Kim S; Noh D; Kwon E; Cho HI
    J Med Virol; 2022 Oct; 94(10):4719-4726. PubMed ID: 35655438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-Based Incidence, Severity, and Risk Factors Associated with Treated Acute-Onset COVID-19 mRNA Vaccination-Associated Hypersensitivity Reactions.
    Macy E; Pandya S; Sheikh J; Burnette A; Shi JM; Chung J; Gin N; Crawford W; Zhang J
    J Allergy Clin Immunol Pract; 2022 Mar; 10(3):827-836. PubMed ID: 34971845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.